🇺🇸 FDA
Patent

US 8580936

Polynucleotides encoding FGFR1-IIIc ECD fusion proteins

granted A61KA61K45/06A61P

Quick answer

US patent 8580936 (Polynucleotides encoding FGFR1-IIIc ECD fusion proteins) held by Five Prime Therapeutics, Inc. expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Five Prime Therapeutics, Inc.
Grant date
Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K45/06, A61P, A61P1/02, A61P1/04